Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker in type 2 diabetes
- PMID: 21820047
- DOI: 10.1016/j.freeradbiomed.2011.07.007
Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker in type 2 diabetes
Abstract
The increasing prevalence of diabetes together with the associated morbidity and mortality calls for additional preventive and therapeutic strategies. New biomarkers that can be used in therapy control and risk stratification as alternatives to current methods are needed and can facilitate a more individualized and sufficient treatment of diabetes. Evidence derived from both epidemiological and mechanistic studies suggests that oxidative stress has an important role in mediating the pathologies of diabetic complications. A marker of intracellular oxidative stress that potentially could be used as a valuable biomarker in diabetes is the DNA oxidation marker 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), which can be assessed noninvasively in the urine, with minimal discomfort for the patient. In this review the analytical validity of 8-oxodG is addressed by highlighting important methodological issues. The available epidemiological evidence regarding urinary 8-oxodG and type 2 diabetes is presented. A possible role for DNA oxidation in cancer development in type 2 diabetes patients is discussed, followed by an evaluation of the potential of urinary 8-oxodG as a clinical biomarker in type 2 diabetes.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.Diabetologia. 2002 Jun;45(6):877-82. doi: 10.1007/s00125-002-0831-8. Epub 2002 May 8. Diabetologia. 2002. PMID: 12107732
-
Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer.Carcinogenesis. 2006 Jun;27(6):1245-50. doi: 10.1093/carcin/bgi313. Epub 2005 Dec 19. Carcinogenesis. 2006. PMID: 16364924
-
Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes.Redox Biol. 2015;4:34-9. doi: 10.1016/j.redox.2014.11.010. Epub 2014 Dec 2. Redox Biol. 2015. PMID: 25498965 Free PMC article.
-
8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009 Apr;27(2):120-39. doi: 10.1080/10590500902885684. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009. PMID: 19412858 Review.
-
Measurement and meaning of oxidatively modified DNA lesions in urine.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):3-14. doi: 10.1158/1055-9965.EPI-07-0751. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18199707 Review.
Cited by
-
Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice.PLoS One. 2012;7(11):e50412. doi: 10.1371/journal.pone.0050412. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226280 Free PMC article.
-
New urinary biomarkers for diabetic kidney disease.Biomark Res. 2013 Feb 4;1(1):9. doi: 10.1186/2050-7771-1-9. Biomark Res. 2013. PMID: 24252392 Free PMC article.
-
The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial.BMJ Open. 2017 May 9;7(5):e014728. doi: 10.1136/bmjopen-2016-014728. BMJ Open. 2017. PMID: 28490557 Free PMC article. Clinical Trial.
-
Assessing Free-Radical-Mediated DNA Damage during Cardiac Surgery: 8-Oxo-7,8-dihydro-2'-deoxyguanosine as a Putative Biomarker.Oxid Med Cell Longev. 2017;2017:9715898. doi: 10.1155/2017/9715898. Epub 2017 Jun 4. Oxid Med Cell Longev. 2017. PMID: 28660009 Free PMC article.
-
Oxidative Damage to the Salivary Glands of Rats with Streptozotocin-Induced Diabetes-Temporal Study: Oxidative Stress and Diabetic Salivary Glands.J Diabetes Res. 2016;2016:4583742. doi: 10.1155/2016/4583742. Epub 2016 Jul 13. J Diabetes Res. 2016. PMID: 27478848 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
